Interim Dean, College of Public Health
Interim Executive Vice President and Provost, The Ohio State University
Administration
The crucial research and policy initiatives in our labs and in our communities enhance the classroom experience for our students — students who will be critical to keeping hope for a healthier, more equitable future alive for decades to come.
Contact
1841 Neil Ave
250 Cunz Hall
Columbus, OH, 43210
Email: zadnik.4@osu.edu
Website:
Karla Zadnik, College of Optometry
College of Public Health Interim Dean Dr. Karla Zadnik is a prominent patient-oriented researcher in the field of optometry and vision sciences.
Zadnik is also serving as interim executive vice president and provost of the university. As interim executive vice president and provost, Zadnik leads Ohio State’s Office of Academic Affairs, which oversees the university’s academic enterprise — including 15 colleges, four regional campuses, University Libraries, and units that support academic experience and operations for the university’s more than 65,000 students and 8,400 faculty members.
Zadnik, formerly dean of the College of Optometry, is also the Glenn A. Fry Professor of Optometry and Physiological Optics and an Ohio State Distinguished Scholar. She serves as the lead dean for the university’s seven health science colleges and chairs the Biomedical Sciences Institutional Review Board. She is a past president of the American Academy of Optometry and the Association of Schools and Colleges of Optometry, and President of the National Board of Examiners in Optometry.
Zadnik received her OD and PhD degrees from the University of California, Berkeley School of Optometry and was the school’s Alumnus of the Year in 2006. Zadnik was the study chair for the National Eye Institute-funded Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study for 20 years. She also chaired the first-ever NEI-funded multicenter study based in optometry, the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Her research funds from the National Institutes of Health total $40 million across her career.
